Drug Approvals
Election Hopes, Buoyant Banks, Labor Labors Less, FDA's Remdesivir Thumbs Up
Plus, a quick look at Southwest Airlines and why it remains the one airline to own.
Take Advantage of Overblown Healthcare Worries With This Trade
Monday's action in Johnson & Johnson is a fadeable event.
Covid Drug Candidates, Buy Eli Lilly? Large Cap Stocks, Tesla Debt Upgrade
Covid itself, and therapeutics or vaccines associated with taking on the SARS-CoV-2 coronavirus, is under a public microscope.
Jim Cramer: Here's How We're Going to Beat Covid-19
Let's talk about what's happening right now to get this thing under control and what it will look like not that long from now.
Should You Invest in Regeneron, Lilly, or Gilead?
Invest either because of their profitable portfolio, their impressive pipeline, or their technical set-up.
Jim Cramer: The President's Behavior Towards Covid-19
I know that Trump's going to blunt our community mask initiative because who needs masks if it isn't a big deal if you are sick?
Shark Bites: Positioning for a Positive Catalyst in Aurinia Pharmaceuticals
AUPH has two very large market opportunities for its voclosporin drug.
The Investment Angle of Covid-19
Stocks of companies that have Covid-19 vaccine candidates have boomed while those in the treatment space have not.
2 Dinged Biotech Stocks That Could Reward Investors in the Months Ahead
Shares of Heron Therapeutics and Myovant Sciences have taken hits but both companies still show promise.
Jim Cramer: Abbott's Rapid Covid-19 Test and My Super Bowl Dreams
Abbott Labs can bring back some normalcy to this country -- and the world -- with its BinaxNOW rapid antigen test along with its amazing Navica app.